Just announced at the 2024 Ascend Rett National Conference, Health Canada has accepted regulatory applications from Acadia Pharmaceuticals for DayBue (Trofinetide), but has also been accepted for a priority review by Health Canada. We were honored to be… Read More
Our annual general meeting is scheduled for September 11, 2024 at 8pm, please save the date. We will continue to share updates on our website and social media accounts.
Code of Conduct
Leave a Comment
Last Updated: 07/22/2024 by Steve
Priority Review by Health Canada
Leave a Comment
Last Updated: 10/25/2024 by Steve
Just announced at the 2024 Ascend Rett National Conference, Health Canada has accepted regulatory applications from Acadia Pharmaceuticals for DayBue (Trofinetide), but has also been accepted for a priority review by Health Canada. We were honored to be… Read More
Annual General Meeting
Leave a Comment
Posted: 06/22/2024 by Steve
Our annual general meeting is scheduled for September 11, 2024 at 8pm, please save the date. We will continue to share updates on our website and social media accounts.